V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20222858 | 20084567 | 1.72 | 45.5 | Palliative (P) | 2018-08-03 | 2018-08-17 | Enzalutamide | 02 | N | OXALIPLATIN + RALTITREXED | 101200002 |
| 20222860 | 20084568 | 1.61 | 104.2 | Palliative (P) | 2019-06-12 | 2019-06-26 | Enzalutamide | 02 | N | CISPLATIN | 101795992 |
| 20222865 | 20084569 | 1.72 | 122 | Palliative (P) | 2019-01-26 | 2019-01-26 | CARBOPLATIN + PACLITAXEL + RT | N | N | CARBOPLATIN + PACLITAXEL + RT | 101405013 |
| 20222870 | 20084570 | 1.64 | 95.25 | 03 | 2017-11-18 | 2017-12-04 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101044078 |
| 20222874 | 20084571 | 1.5 | 72 | Palliative (P) | 2015-10-15 | 2015-10-22 | Enzalutamide | 02 | N | OCTREOTIDE | 101322772 |
| 20222875 | 20084572 | 1.71 | 71 | 03 | 2016-06-04 | 2016-06-13 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 100581815 |
| 20222877 | 20084573 | 1.82 | 86 | 03 | 2018-12-26 | 2018-12-30 | CARBOPLATIN + PACLITAXEL + RT | N | N | CARBOPLATIN + PACLITAXEL + RT | 101351080 |
| 20222879 | 20084574 | 1.55 | 60 | Curative (C) | 2017-06-12 | 2017-06-26 | Enzalutamide | N | N | CAPECITABINE + CISPLATIN + RT | 101275119 |
| 20222880 | 20084575 | null | null | Palliative (P) | 2014-07-16 | 2014-08-01 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 101853277 |
| 20222881 | 20084576 | 1.74 | 71.8 | Palliative (P) | null | 2017-10-24 | Mitomycin Intravesical | N | Y | MITOMYCIN INTRAVESICULAR | 100700003 |
| 20222885 | 20084577 | 1.78 | 56 | Palliative (P) | 2017-12-06 | 2017-12-29 | Cisplatin | N | N | CISPLATIN | 101707066 |
| 20222887 | 20084578 | 1.71 | 48.9 | Curative (C) | 2017-01-13 | 2017-02-07 | Enzalutamide | 1 | N | CISPLATIN | 100230883 |
| 20222889 | 20084579 | 0 | 0 | Palliative (P) | null | 2017-06-24 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 101848171 |
| 20222901 | 20084580 | 1.81 | 89.4 | Palliative (P) | 2019-03-19 | 2019-03-19 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101258540 |
| 20222906 | 20084581 | 1.59 | 51 | Palliative (P) | 2018-04-10 | 2018-04-11 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101095083 |
| 20222910 | 20084582 | 1.61 | 72 | Neo-adjuvant (N) | 2018-03-26 | 2018-04-02 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100916987 |
| 20222913 | 20084583 | 1.69 | 82.5 | Palliative (P) | 2016-01-10 | 2016-06-28 | Enzalutamide | 02 | N | MITOMYCIN INTRAVESICULAR | 100627973 |
| 20222918 | 20084584 | 1.57 | 76.4 | Palliative (P) | null | 2016-02-26 | Mitomycin Intravesical | N | N | MITOMYCIN INTRAVESICULAR | 100865299 |
| 20222920 | 20084585 | 1.7 | 77.7 | Curative (C) | 2016-01-10 | 2016-02-06 | Capecitabine + Cisplatin + RT | 02 | N | CISPLATIN | 100413395 |
| 20222922 | 20084586 | 0 | 0 | Neo-adjuvant (N) | 2017-09-25 | 2017-10-22 | CARBOPLATIN + PACLITAXEL + RT | N | null | CARBOPLATIN + PACLITAXEL + RT | 101777642 |
| 20222926 | 20084587 | 1.59 | 83.9 | null | 2019-06-14 | 2019-06-14 | Enzalutamide | 02 | null | CISPLATIN | 100255792 |
| 20222929 | 20084588 | 1.8 | null | Curative (C) | 2017-05-04 | 2017-06-01 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | N | CARBOPLATIN + GEMCITABINE | 101309276 |
| 20222936 | 20084589 | 1.8 | 59.7 | Palliative (P) | 2019-10-06 | 2019-10-06 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | N | CISPLATIN | 100776878 |
| 20222938 | 20084590 | 1.78 | 57 | Palliative (P) | 2019-07-06 | 2019-07-06 | Enzalutamide | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101013428 |
| 20222946 | 20084591 | 1.83 | 90.6 | Neo-adjuvant (N) | 2016-10-11 | 2016-10-11 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100225500 |
| 20222947 | 20084592 | 1.54 | 55 | null | 2018-03-24 | 2018-03-24 | Enzalutamide | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100062730 |
| 20222949 | 20084593 | 1.65 | 69.8 | null | null | 2018-03-18 | Enzalutamide | 99 | null | ENZALUTAMIDE | 101653649 |
| 20222950 | 20084594 | 1.54 | 56.25 | Curative (C) | 2019-04-13 | 2019-04-20 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100263864 |
| 20222951 | 20084595 | 1.64 | 88 | Palliative (P) | 2020-01-16 | 2020-01-16 | Enzalutamide | null | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101348673 |
| 20222955 | 20084596 | 1.6 | 79 | Neo-adjuvant (N) | 2016-10-25 | 2016-10-31 | Capecitabine + Cisplatin + RT | N | Y | ATEZOLIZUMAB + BEVACIZUMAB | 100890528 |
| 20222963 | 20084597 | 1.59 | 72.3 | null | 2018-11-30 | 2019-04-20 | Enzalutamide | 02 | null | CETUXIMAB + OXALIPLATIN + MDG | 101341877 |
| 20222964 | 20084598 | 1.55 | 45.8 | Palliative (P) | 2021-04-05 | 2021-04-05 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100461281 |
| 20222975 | 20084599 | 1.62 | 63.2 | Curative (C) | 2019-08-11 | 2019-08-11 | Capecitabine + Cisplatin + RT | 02 | Y | CAPECITABINE + CISPLATIN + RT | 100989336 |
| 20223003 | 20084600 | 1.76 | 60.4 | null | 2019-03-29 | 2019-03-29 | Enzalutamide | 2 | N | OCTREOTIDE | 101476351 |
| 20223006 | 20084601 | 1.65 | 50.6 | null | 2018-02-01 | 2018-02-02 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100965959 |
| 20223021 | 20084602 | 1.55 | 66.1 | Palliative (P) | 2019-12-10 | 2019-12-11 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100762068 |
| 20223028 | 20084603 | 1.54 | 73.1 | Curative (C) | 2019-06-12 | 2019-06-17 | TRASTUZUMAB | N | N | SCALOP-2 TRIAL | 101365062 |
| 20223031 | 20084604 | 1.6 | null | null | 2016-11-01 | 2016-11-29 | Enzalutamide | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100271808 |
| 20223035 | 20084605 | 1.51 | 135 | Neo-adjuvant (N) | 2018-06-22 | 2018-07-30 | OCTREOTIDE | 02 | N | OCTREOTIDE | 101212277 |
| 20223043 | 20084606 | 1.69 | 70.5 | Palliative (P) | 2018-03-01 | 2018-03-01 | TRASTUZUMAB | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100807007 |
| 20223044 | 20084607 | 1.72 | 63.3 | null | 2017-09-24 | 2017-09-24 | Enzalutamide | 02 | null | TRASTUZUMAB | 101728019 |
| 20223047 | 20084608 | 1.58 | 75.3 | null | 2017-08-21 | 2017-08-21 | Capecitabine + Cisplatin + RT | null | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101189490 |
| 20223048 | 20084609 | 1.68 | 126.9 | Palliative (P) | 2019-12-23 | 2019-12-23 | Enzalutamide | 02 | Y | CETUXIMAB | 100399053 |
| 20223053 | 20084610 | 1.79 | 65.7 | null | 2020-01-08 | 2020-01-09 | Mitomycin Intravesical | 02 | null | MITOMYCIN INTRAVESICULAR | 100943513 |
| 20223054 | 20084611 | 1.77 | 46.8 | null | 2019-08-03 | 2019-09-01 | Enzalutamide | 02 | null | CARBOPLATIN + GEMCITABINE | 100490988 |
| 20223058 | 20084612 | 1.67 | 68.3 | Palliative (P) | 2016-06-24 | 2016-06-24 | Enzalutamide | 02 | N | CETUXIMAB | 100403859 |
| 20223061 | 20084613 | 1.73 | 70.3 | Palliative (P) | 2016-07-19 | 2016-07-19 | Enzalutamide | null | N | CAPECITABINE + TEMOZOLOMIDE | 100998203 |
| 20223075 | 20084614 | 1.7 | 98.9 | Palliative (P) | null | 2017-05-22 | Oxaliplatin + Raltitrexed | N | N | OXALIPLATIN + RALTITREXED | 101064583 |
| 20223077 | 20084615 | 1.8 | 76.1 | Palliative (P) | null | 2016-12-01 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 101816521 |
| 20223079 | 20084616 | null | 63.5 | Curative (C) | 2019-04-08 | 2019-04-09 | Enzalutamide | 02 | N | ECF | 100032035 |